Free Trial

Gilead Sciences (GILD) Earnings Date, Estimates & Call Transcripts

Gilead Sciences logo
$88.40 -3.71 (-4.03%)
(As of 11/15/2024 ET)

Gilead Sciences Latest Earnings Summary

Upcoming Q4
Earnings Date
Feb. 4Estimated
Actual EPS
(Nov. 6)
$2.02 Beat By $0.44
Consensus EPS
(Nov. 6)
$1.58

Gilead Sciences issued Q3 2024 earnings on November 6, 2024, reporting an EPS of $2.02, which topped analysts' consensus estimates of $1.58 by $0.44. Quarterly revenue rose 7.0% year-over-year to $7.55 billion, above the consensus estimate of $7.01 billion. With a trailing EPS of $0.09 and a P/E Ratio of 982.22, Gilead Sciences' earnings are expected to grow 68.95% next year, from $4.38 to $7.40 per share.

GILD Upcoming Earnings

Gilead Sciences' next earnings date is estimated for Tuesday, February 4, 2025, based off prior year's reporting schedules.

Get Gilead Sciences Earnings Alerts

Want to stay updated on the latest earnings announcements and upcoming reports? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Gilead Sciences and other key companies, straight to your inbox.

Sign Up
Skip Charts & View Estimated and Actual Earnings Data

GILD Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

GILD Estimated and Actual Revenue by Quarter

The chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter.

Gilead Sciences Analyst EPS Estimates

QuarterNumber of EstimatesLow EstimateHigh EstimateAverage EstimateCompany Guidance
Q1 20244-$1.42$1.97$0.94 
Q2 20244$1.51$1.98$1.75 
Q3 20244$1.58$2.10$1.86 
Q4 20244$1.45$1.86$1.75 
FY 202416$3.12$7.91$6.31 
Q1 20251$1.63$1.63$1.63 
Q2 20251$1.72$1.72$1.72 
Q3 20251$2.04$2.04$2.04 
Q4 20251$1.80$1.80$1.80 
FY 20254$7.19$7.19$7.19 
Q1 20261$1.62$1.62$1.62 
Q2 20261$1.82$1.82$1.82 
Q3 20261$2.11$2.11$2.11 

Gilead Sciences Earnings History by Quarter

DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueLinks
2/4/2025
(Estimated)
------- 
11/6/2024Q3 2024$1.58$2.02+$0.44$3.04$7.01B$7.55B        
8/8/2024Q2 2024$1.61$2.01+$0.40$2.73$6.64B$6.95B
4/25/2024Q1 2024-$1.49-$1.32+$0.17$0.70$6.36B$6.69B        
2/6/2024Q4 2023$1.76$1.72 -$0.04$2.30$7.10B$7.12B        
11/7/2023Q3 2023$1.91$2.29+$0.38$2.85$6.81B$7.05B          
8/3/2023Q2 2023$1.64$1.34 -$0.30$1.85$6.45B$6.60B        
4/27/2023Q1 2023$1.63$1.37 -$0.26$1.94$6.33B$6.35B        
2/2/2023Q4 2022$1.50$1.67+$0.17$2.04$6.63B$7.39B        

Gilead Sciences Earnings - Frequently Asked Questions

Gilead Sciences has not confirmed its next earnings publication date, but the company's estimated earnings date is Tuesday, February 4th, 2025 based off last year's report dates. Learn more on GILD's earnings history.

Gilead Sciences issued an update on its FY 2024 earnings guidance on Wednesday, November, 6th. The company provided earnings per share (EPS) guidance of 4.250-4.450 for the period, compared to the consensus earnings per share estimate of 3.810. The company issued revenue guidance of $27.8 billion-$28.1 billion, compared to the consensus revenue estimate of $27.7 billion.

In the previous quarter, Gilead Sciences (NASDAQ:GILD) reported $2.02 earnings per share (EPS) to beat the analysts' consensus estimate of $1.58 by $0.44. Learn more on analysts' earnings estimate vs. GILD's actual earnings.

The conference call for Gilead Sciences's latest earnings report can be listened to online.
Listen to Conference Call

The conference call transcript for Gilead Sciences's latest earnings report can be read online.
Read Transcript

Gilead Sciences (NASDAQ:GILD) has a recorded annual revenue of $27.12 billion.

Gilead Sciences (NASDAQ:GILD) has a recorded net income of $5.67 billion. GILD has generated $0.09 earnings per share over the last four quarters.

Gilead Sciences (NASDAQ:GILD) has a trailing price-to-earnings ratio of 982.22 and a forward price-to-earnings ratio of 20.18. The price/earnings-to-growth ratio is 2.72.

Gilead Sciences's earnings are expected to grow from $4.38 per share to $7.40 per share in the next year, which is a 68.95% increase.

`

More Earnings Resources from MarketBeat



This page (NASDAQ:GILD) was last updated on 11/17/2024 by MarketBeat.com Staff
From Our Partners